We are live on ! Find out more
BDR

Blonder Tongue Laboratories Inc

Delisted

BDR was delisted on the 24th of June, 2022.

0 hedge funds and large institutions have $0 invested in Blonder Tongue Laboratories Inc in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 110 (-11)

100% less capital invested

Capital invested by funds: $391K → $0 (-$391K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 11

Holders
Holders Change
-11
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TCM
1
Tufton Capital Management
Maryland
-$120K -188,940 Closed
Renaissance Technologies
2
Renaissance Technologies
New York
-$64K -99,449 Closed
BCM
3
Bridgeway Capital Management
Texas
-$58K -90,000 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
-$52K -81,448 Closed
State Street
5
State Street
Massachusetts
-$42K -65,600 Closed
VF
6
Virtu Financial
New York
-$32K -49,857 Closed
Citadel Advisors
7
Citadel Advisors
Florida
-$14K -21,950 Closed
UBS Group
8
UBS Group
Switzerland
-$6K -9,435 Closed
TRCT
9
Tower Research Capital (TRC)
New York
-$3K -5,127 Closed

BDR Hedge Fund Activity: Q2 2022 in Review

0 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q2 2022, worth a combined $0 — down 100% from $391K a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of BDR and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tufton Capital Management, exiting entirely with an estimated $120K sold.

  • 0 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q2 2022, down from 11 in Q1 2022.
  • Funds reported $0 of Blonder Tongue Laboratories Inc stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Blonder Tongue Laboratories Inc positions in Q2 2022 and 11 closed out, a net change of -11 holders.
  • The largest Blonder Tongue Laboratories Inc seller in Q2 2022 was Tufton Capital Management, an estimated $120K sold.

Based on aggregated 13F filings for Q2 2022.